Search research articles
Contact Us
Filters
Showing results (531-540 of 638) with videos related to
Page
of 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect
M Nishizaki, T Fujiwara, T Tanida, et al.
Current Problems in Surgery
|
November 1, 1996
Treatment of the patient with lung metastases
J A Roth, D J Beech, J B Putnam, et al.
Oncogene
|
March 4, 2000
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells
J Shao, T Fujiwara, Y Kadowaki, et al.
American Journal of Clinical Oncology
|
March 10, 2001
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction
I I Schnirer, R Komaki, J C Yao, et al.
Carcinogenesis
|
September 1, 1995
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype
X Jin, X Wu, J A Roth, et al.
The Journal of Experimental Medicine
|
October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
E A Grimm, R J Robb, J A Roth, et al.
Human Cell
|
March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]
T Fujiwara, S Kagawa, N Ogawa, et al.
American Journal of Veterinary Research
|
August 1, 1980
Thymic abnormalities and growth hormone deficiency in dogs
J A Roth, L G Lomax, N Altszuler, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 8, 2000
Effects of danofloxacin and tilmicosin on circulating neutrophils in beef heifers
V R Fajt, M D Apley, J A Roth, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers
M Hamada, T Fujiwara, A Hizuta, et al.
Page
of 64
Search research articles
Search
Showing results (531-540 of 638) with videos related to
Sort By:
Page
of 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect
M Nishizaki, T Fujiwara, T Tanida, et al.
Current Problems in Surgery
|
November 1, 1996
Treatment of the patient with lung metastases
J A Roth, D J Beech, J B Putnam, et al.
Oncogene
|
March 4, 2000
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells
J Shao, T Fujiwara, Y Kadowaki, et al.
American Journal of Clinical Oncology
|
March 10, 2001
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction
I I Schnirer, R Komaki, J C Yao, et al.
Carcinogenesis
|
September 1, 1995
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype
X Jin, X Wu, J A Roth, et al.
The Journal of Experimental Medicine
|
October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
E A Grimm, R J Robb, J A Roth, et al.
Human Cell
|
March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]
T Fujiwara, S Kagawa, N Ogawa, et al.
American Journal of Veterinary Research
|
August 1, 1980
Thymic abnormalities and growth hormone deficiency in dogs
J A Roth, L G Lomax, N Altszuler, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 8, 2000
Effects of danofloxacin and tilmicosin on circulating neutrophils in beef heifers
V R Fajt, M D Apley, J A Roth, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers
M Hamada, T Fujiwara, A Hizuta, et al.
Page
of 64